Submitted by Anonymous (not verified) on 12 October 2023 - 13:40
Opinion/decision on a Paediatric investigation plan (PIP): Glucagon analogue linked to a human immunoglobulin Fc fragment, decision type: , therapeutic area: , PIP number: P/0468/2022
Source: